Mexico Approves Commercial Use of Pfizer and Moderna COVID-19 Vaccines: Cofepris Announcement

Mexico City, Dec 7 (EFE).- The Federal Commission for the Protection Against Health Risks (Cofepris) approved this Thursday the health registration for the Pfizer and Moderna anti-covid vaccines, so they can be marketed in Mexico.

“The simultaneous ruling to issue health registration for vaccines against COVID-19, allowing their marketing in Mexico, sets a precedent towards a regulation focused on guaranteeing access without benefiting any user in particular, and eliminating any need for an intermediary or manager,” he indicated. Cofepris in a statement.

On November 28, the regulatory body postponed the approval because, as it argued, the pharmaceutical companies had asked for more time to resolve the technical information that was missing to obtain the health registration.

Cofepris noted that this regulatory process, “a pioneer in the world,” was achieved in record time “after the rigorous technical analysis of the specialized personnel of this health authority and the evaluation of the clinical performance of these biological vaccines in the sessions of the Committee on New Molecules (CMN), which were public for the first time.”

He stated that, in a “transparent and timely” manner, a multidisciplinary team of federal personnel determined that the Pfizer and Moderna biologics “met the quality, safety and efficacy requirements, in the files presented to this federal commission.”

Likewise, he said that the simultaneous approval to issue this health registration for these vaccines sets a precedent for a regulation focused on guaranteeing access “without benefiting any user in particular, and eliminating any need for an intermediary or manager.”

The institution urged the population not to make indiscriminate use of any covid-19 vaccine, since the risk-benefit of each application must be considered, and reiterated that the application of vaccines outside the National Vaccination Policy “must be under strict recommendation.” medical.”

“The supply of these biologicals must be under medical supervision and should not be applied indiscriminately, as they may represent health risks.”

The Government of Mexico has the goal of applying this cold season 35.2 million vaccines against influenza and 19.4 million against covid-19, a disease for which it will use the Abdala biological, made in Cuba, and the Sputnik, from Russia.

However, the World Health Organization (WHO) has not endorsed the use of any of these drugs as a booster against covid-19, although last October, the Mexican president, Andrés Manuel López Obrador, supported their effectiveness after being vaccinated in I live with Abdala’s.

Although these vaccines are free for now, López Obrador has promised that people will be able to buy those from other pharmaceutical companies, such as Pfizer and Moderna, but we will have to wait for the approval of commercial use of Cofepris.

2023-12-07 20:33:00
#Mexico #approves #marketing #anticovid #vaccines #Pfizer #Moderna